Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Canarypox HIV vaccine responses in phase II not sufficient for phase III investigation

Feb. 20, 2007

Merck begins registrations of Atripla in developing countries

Feb. 20, 2007

Conditional approval for Prezista in E.U.

Feb. 19, 2007

Trend toward stabilization of CD4+ count in patients receiving Remune, IR-103

Feb. 19, 2007

Accelerated reviews for maraviroc

Feb. 14, 2007

Guangdong Lantai Viewland to develop MIV-160 for China

Feb. 13, 2007

AGS-004 studied in phase I/II trial in HIV-infected adults

Feb. 13, 2007

Low-dose interferon alpha lozenges studied for HIV patients with oral warts

Feb. 13, 2007

First large-scale HIV trial begins in South Africa

Feb. 13, 2007

Recent patents report novel therapeutic agents for HIV infection

Feb. 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...